WallStSmart
BNGO

Bionano Genomics Inc

NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$1.16
-2.52% today

Updated 2026-04-29

Market cap
$13.42M
P/E ratio
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
52W range
$1 – $6
Volume
0.3M

Bionano Genomics Inc (BNGO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$6.79M$9.51M$12.00M$10.13M$8.50M$17.98M$27.80M$36.12M$30.78M$28.51M
Revenue growth (YoY)+39.9%+26.3%-15.6%-16.1%+111.5%+54.6%+29.9%-14.8%-7.4%
Cost of revenue$3.58M$6.03M$8.71M$6.77M$5.73M$14.11M$21.86M$26.55M$30.40M$22.25M
Gross profit$3.21M$3.47M$3.29M$3.36M$2.77M$3.87M$5.95M$9.57M$380000.00$6.26M
Gross margin47.3%36.6%27.4%33.2%32.6%21.5%21.4%26.5%1.2%22.0%
R&D$11.43M$12.01M$9.48M$9.08M$10.26M$22.48M$49.05M$54.03M$24.80M$11.37M
SG&A$12.95M$14.08M$14.22M$20.16M$31.07M$58.49M$88.60M$93.50M$51.85M$35.15M
Operating income$-21.17M$-23.22M$-20.42M$-25.87M$-38.55M$-77.10M$-131.70M$-215.25M$-103.98M$-33.34M
Operating margin-311.6%-244.3%-170.1%-255.4%-453.4%-428.8%-473.7%-596.0%-337.9%-116.9%
EBITDA$-17.25M$-21.25M$-15.78M$-24.75M$-37.07M$-73.86M$-120.31M$-213.60M$-97.47M$-23.61M
EBITDA margin-254.0%-223.6%-131.5%-244.3%-436.0%-410.7%-432.8%-591.4%-316.7%-82.8%
EBIT$-18.37M$-22.76M$-17.10M$-25.87M$-38.55M$-77.22M$-130.41M$-227.31M$-111.69M$-33.34M
Interest expense$470072.00$590927.00$1.38M$2.29M$2.52M$927000.00$298000.00$5.12M$289000.00$298000.00
Income tax$12924.00$18552.00$15511.00$21048.00$29193.00$-5.72M$1.88M$62000.00$33000.00
Effective tax rate-0.1%-0.1%-0.1%-0.1%-0.1%7.3%-1.4%-0.0%-0.0%0.0%
Net income$-18.85M$-23.37M$-18.50M$-29.84M$-41.14M$-72.44M$-132.60M$-232.49M$-112.02M$-26.39M
Net income growth (YoY)-24.0%+20.8%-61.3%-37.9%-76.1%-83.1%-75.3%+51.8%+76.4%
Profit margin-277.5%-245.8%-154.1%-294.5%-483.8%-402.8%-476.9%-643.7%-364.0%-92.6%